Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.
- DOI
- 10.1038/s41375-025-02767-4
- Published
- 2025 Dec
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41375-025-02767-4,
title = {Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.},
author = {Pollyea D and Kerre T and Deeren D and Beguin Y and Lin TL and Sallman DA and Anguille S and Blum WG and Flament A and Breman E and Lonez C},
year = {2025},
journal = {Leukemia},
doi = {10.1038/s41375-025-02767-4},
url = {https://doi.org/10.1038/s41375-025-02767-4}
}RIS
TY - JOUR TI - Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia. AU - Pollyea D AU - Kerre T AU - Deeren D AU - Beguin Y AU - Lin TL AU - Sallman DA AU - Anguille S AU - Blum WG AU - Flament A AU - Breman E AU - Lonez C PY - 2025 JO - Leukemia DO - 10.1038/s41375-025-02767-4 UR - https://doi.org/10.1038/s41375-025-02767-4 ER -
APA
D, P., T, K., D, D., Y, B., TL, L., DA, S., S, A., WG, B., A, F., E, B., & C, L. (2025). Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.. Leukemia. https://doi.org/10.1038/s41375-025-02767-4
Source records
- pubmed · retrieved 2026-09-25T11:45:50.607Z
- europe-pmc · retrieved 2026-09-25T11:45:50.618Z